Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez, Sección XVI, 14080, Mexico City, Mexico.
Clinical Epidemiology Unit, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Mexico City, Mexico.
Arthritis Res Ther. 2021 Feb 22;23(1):61. doi: 10.1186/s13075-021-02440-y.
Assessing risk perception (RP) helps explain how rheumatoid arthritis (RA) patients integrate their ideas concerning the disease and how this understanding affects their self-care management. Compliance with treatment impacts disease-related outcomes and could be associated with RP to variable degrees and at different levels. The primary objective was to determine a potential association between RP and compliance with therapy in RA outpatients and to identify additional factors. The secondary objective was to identify factors associated with judgment bias such as unrealistic RP.
Between January 2018 and June 2019, 450 consecutive outpatients who received RA-related treatment were invited to a face-to-face interview to obtain socio-demographic data, RA-related information, comorbidities, and the following outcomes: adherence, persistence, and concordance with medications assessed with a questionnaire locally designed; RP with the RP questionnaire (RPQ); disease activity with the Routine Assessment of Patient Index Data-3 (RAPID-3); disability with the Health Assessment Questionnaire Disability Index (HAQ-DI); quality of life with Medical Outcomes Study Short Form-36 (SF-36) instrument; pain and overall disease with the respective visual analogue scale (VAS); and health literacy assessed with 3 questions. Significant RP was defined according to a cut-off based on the 75th percentile value of the sample in which the RPQ was validated. Unrealistic RP was defined based on the coincidence of the presence/absence of significant RP and less/more than 7 unfavorable medical criteria. Multiple logistic regression analysis was used. Patients provided written informed consent and the study received Internal Review Board approval.
There were 415 patients included, primarily middle-aged women with long-standing disease and moderate disease activity. Almost half of the patients were receiving corticosteroids and 15.9% intensive RA-related treatment. There were 44.1% of the patients concordant with treatment and 22.6% had significant RP. The patients' treatment behavior was not retained in the regression analysis; meanwhile, rheumatoid nodes, surgical joint replacement, family history of RA, and higher RAPID-3 score were associated with significant RP. There were 56 patients with unrealistic RP; significant RP and more unfavorable medical criteria were associated with unrealistic RP.
Compliance with therapy was not associated with significant RP in RA outpatients.
评估风险感知(RP)有助于解释类风湿关节炎(RA)患者如何整合他们对疾病的看法,以及这种理解如何影响他们的自我护理管理。治疗依从性会影响与疾病相关的结果,并且可能与 RP 存在不同程度和不同层次的关联。主要目的是确定 RA 门诊患者的 RP 与治疗依从性之间的潜在关联,并确定其他因素。次要目的是确定与判断偏差相关的因素,例如不切实际的 RP。
2018 年 1 月至 2019 年 6 月,邀请 450 名连续接受 RA 相关治疗的门诊患者进行面对面访谈,以获取社会人口统计学数据、RA 相关信息、合并症以及以下结果:使用当地设计的问卷评估的药物依从性、持久性和一致性;使用 RP 问卷(RPQ)评估 RP;使用常规评估患者指数数据-3(RAPID-3)评估疾病活动度;使用健康评估问卷残疾指数(HAQ-DI)评估残疾程度;使用医疗结局研究 36 项简短形式(SF-36)量表评估生活质量;使用各自的视觉模拟量表(VAS)评估疼痛和整体疾病;使用 3 个问题评估健康素养。根据验证 RPQ 的样本中第 75 百分位值的截止值,确定显著 RP。根据显著 RP 和少于/多于 7 个不利医学标准的存在/不存在,确定不切实际的 RP。采用多因素逻辑回归分析。患者提供书面知情同意,研究获得内部审查委员会批准。
共有 415 名患者入选,主要为中年女性,疾病病程长,疾病活动度中度。近一半的患者正在接受皮质类固醇治疗,15.9%接受强化 RA 相关治疗。有 44.1%的患者治疗依从性好,22.6%的患者有显著的 RP。患者的治疗行为并未保留在回归分析中;然而,类风湿结节、关节置换术、RA 家族史和更高的 RAPID-3 评分与显著的 RP 相关。有 56 名患者有不切实际的 RP;显著的 RP 和更多不利的医学标准与不切实际的 RP 相关。
RA 门诊患者的治疗依从性与显著的 RP 无关。